2001 (8) TMI 757 - AT - Central Excise

Summary

The Appellate Tribunal CEGAT, Mumbai considered the liability to duty of glipizide, a bulk drug, used by the appellant in manufacturing glynase. The department applied different prices for valuation, based on sales to different buyers. The appellant argued for a lower price based on a larger quantity sold to another buyer, but the tribunal upheld the department's valuation method. The appeal was dismissed.